SB
TEVA icon

SIG Brokerage’s Teva Pharmaceuticals TEVA Stock Holding History

SIG Brokerage’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,000
Closed -$780K – 968
2025
Q4 		$780K Buy
+25,000
New +$616K 0.02% 402
2025
Q2 		– Sell
-144,600
Closed -$2.22M – 854
2025
Q1 		$2.22M Hold
144,600
– – 0.11% 155
2024
Q4 		$3.19M Buy
+144,600
New +$2.63M 0.17% 92

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIG Brokerage's TEVA Position: Q1 2026 in Review

SIG Brokerage opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 38,467 shares worth $1.16M. The stake represents 0.03% of the portfolio and ranks #399 among its holdings. This is a return to the name: SIG Brokerage previously reported a position in TEVA as recently as Q1 2025.

SIG Brokerage first reported a position in TEVA in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.38M in Q4 2024. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • SIG Brokerage held 38,467 shares of Teva Pharmaceuticals worth $1.16M as of Q1 2026.
  • Teva Pharmaceuticals was a new SIG Brokerage position in Q1 2026.
  • Teva Pharmaceuticals made up 0.03% of SIG Brokerage's portfolio in Q1 2026, its #399 holding.
  • SIG Brokerage first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • SIG Brokerage's Teva Pharmaceuticals position peaked at $1.38M in Q4 2024.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on SIG Brokerage's 13F filing for Q1 2026, filed 15 May 2026.